Potassium Channels in Parkinson's Disease: Potential Roles in its Pathogenesis and Innovative Molecular Targets for Treatment

Xiaoyi Chen; Yunjiang Feng; Ronald J Quinn; Dean L Pountney; Des R. Richardson; George D Mellick; Linlin Ma

doi:10.1124/pharmrev.122.000743

Article Information

PHARMREV-AR-2022-000743

DOI

https://doi.org/10.1124/pharmrev.122.000743

PubMed

36918260

Published By

American Society for Pharmacology and Experimental Therapeutics

Print ISSN

0031-6997

Online ISSN

1521-0081

History

Published online March 14, 2023.

© 2023 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.

Author Information

Xiaoyi Chen1,
Yunjiang Feng2,
Ronald J Quinn1,
Dean L Pountney3,
Des R. Richardson4,*,
George D Mellick2,*, and
Linlin Ma2,*

¹Griffith Institute for Drug Discovery, Griffith University, Australia
²Griffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Australia
³School of Pharmacy and Medical Science, Griffith University, Australia
⁴Department of Pathology, University of Sydney, Australia

↵* Corresponding Author:
Linlin Ma, Griffith Institute for Drug Discovery, School of Environment and Science, Griffith University, 46 Don Young Road, Nathan, Brisbane, N/A, 4111, Australia. E-mail: linlin.ma{at}griffith.edu.au
* Corresponding Author; email: d.richardson{at}griffith.edu.au
* Corresponding Author; email: g.mellick{at}griffith.edu.au